Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;107(1):30-41.
doi: 10.1007/s00392-017-1155-5. Epub 2017 Aug 24.

Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals

Farbod Sedaghat-Hamedani  1   2 , Elham Kayvanpour  1   2 , Oguz Firat Tugrul  1   2 , Alan Lai  1 , Ali Amr  1   2 , Jan Haas  1   2 , Tanja Proctor  3 , Philipp Ehlermann  1 , Katrin Jensen  3 , Hugo A Katus  1   2 , Benjamin Meder  4   5
Affiliations
Review

Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals

Farbod Sedaghat-Hamedani et al. Clin Res Cardiol. 2018 Jan.

Abstract

Background: Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease, which goes along with increased risk for sudden cardiac death (SCD). Despite the knowledge about the different causal genes, the relationship between individual genotypes and phenotypes is incomplete.

Methods and results: We retrieved PubMed/Medline literatures on genotype-phenotype associations in patients with HCM and mutations in MYBPC3, MYH7, TNNT2, and TNNI3. Altogether, 51 studies with 7675 HCM patients were included in our meta-analysis. The average frequency of mutations in MYBPC3 (20%) and MYH7 (14%) was higher than TNNT2 and TNNI3 (2% each). The mean age of HCM onset for MYH7 mutation positive patients was the beginning of the fourth decade, significantly earlier than patients without sarcomeric mutations. A high male proportion was observed in TNNT2 (69%), MYBPC3 (62%) and mutation negative group (64%). Cardiac conduction disease, ventricular arrhythmia and heart transplantation (HTx) rate were higher in HCM patients with MYH7 mutations in comparison to MYBPC3 (p < 0.05). Furthermore, SCD was significantly higher in patients with sarcomeric mutations (p < 0.01).

Conclusion: A pooled dataset and a comprehensive genotype-phenotype analysis show that the age at disease onset of HCM patients with MYH7 is earlier and leads to a more severe phenotype than in patient without such mutations. Furthermore, patients with sarcomeric mutations are more susceptible to SCD. The present study further supports the clinical interpretation of sarcomeric mutations in HCM patients.

Keywords: Genotype–phenotype correlation; Hypertrophic cardiomyopathy; Sarcomeric mutations.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Circ Cardiovasc Genet. 2013 Feb;6(1):19-26 - PubMed
    1. Mol Biol Cell. 2013 Dec;24(24):3805-18 - PubMed
    1. J Clin Invest. 2008 Dec;118(12 ):3893-903 - PubMed
    1. J Am Coll Cardiol. 2004 Nov 2;44(9):1903-10 - PubMed
    1. Circ Cardiovasc Genet. 2014 Aug;7(4):401-4 - PubMed

MeSH terms

LinkOut - more resources